Ambrosia Drugs Profile
Key Indicators
- Authorised Capital ₹ 8.50 M
as on 08-11-2024
- Paid Up Capital ₹ 0.50 M
as on 08-11-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.67 Cr
as on 08-11-2024
- Satisfied Charges ₹ 5.88 Cr
as on 08-11-2024
- Revenue -41.85%
(FY 2022)
- Profit 213.97%
(FY 2022)
- Ebitda 717.10%
(FY 2022)
- Net Worth -20.80%
(FY 2022)
- Total Assets -7.00%
(FY 2022)
About Ambrosia Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 8.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.67 Cr. The company has closed loans amounting to ₹5.88 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Arora and Anuj Kumar serve as directors at the Company.
- CIN/LLPIN
U51397UR2004PTC028742
- Company No.
028742
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2004
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- LocationHaridwar, Uttarakhand
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ambrosia Drugs Private Limited offer?
Ambrosia Drugs Private Limited offers a wide range of products and services, including Injectable Products, Pharmaceutical Injectables, Fitness Supplements, Coenzyme Q10 Tablets and Capsules, Multivitamin Syrup & Drops, Multivitamin Drops, Pain Killers, Forte Tablets, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Ambrosia Drugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Arora  | Director | 30-Sep-2014 | Current |
| Anuj Kumar | Additional Director | 12-Jan-2019 | Current |
Financial Performance of Ambrosia Drugs.
Ambrosia Drugs Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.85% decrease. The company also saw a substantial improvement in profitability, with a 213.97% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ambrosia Drugs?
Unlock access to Ambrosia Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Feb 2018 | ₹2.54 M | Open |
Others Creation Date: 11 Feb 2018 | ₹4.41 Cr | Open |
Others Creation Date: 27 Jan 2016 | ₹3.50 Cr | Satisfied |
How Many Employees Work at Ambrosia Drugs?
Unlock and access historical data on people associated with Ambrosia Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ambrosia Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ambrosia Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
